baber/WOPTO huggingface dataset:
Patent NZ-228510-A (NZ)
Title: Membrane separation system: membranes partially immersed in permeate
Inventor: SLEGERS JOHN
IPC: B01D61/00
Filed: 1989-03-29
Abstract: An improved method of operating a membrane separation system is provided, which comprises applying a reduced pressure to one side of the or each membrane to thereby cause fluid to be drawn through the or each membrane from the other side thereof. As the method does not utilize fluid under pressure, which has typically been required in prior art procedures, the risk of damage to the membranes is eliminated, or at least minimised.
Patent NZ-231348-A (NZ)
Title: Shower rose assembly
Inventor: MCCABE STEPHEN CHARLES
IPC: B05B1/18
Filed: 1989-11-09
Abstract: A shower rose or head assembly includes a supply device (16) and a pair of shower roses or heads (10). Each head includes a chamber into which water can be supplied from a common water supply via the supply device, and at least one wall through which a plurality of outlet apertures (38) are provided and from which water can issue from the chamber in a plurality of narrow streams. A valve assembly (28) is also provided serving to close off the supply of water to the shower head (11). The chamber of each shower head has an internal cross-sectional dimension smaller than for a conventional shower head thus providing a constriction in the flow path through the assembly, whilst the supply device contains a branch conduit (17) which serves to provide a further constriction in the flow path through the assembly. The constrictions serve to reduce the rate of flow of water through the assembly.
Patent NZ-233656-A (NZ)
Title: Preparation of 7-acylamino-2-carboxyalkyl-3-exo-methylene cephamsulphoxide derivatives by cyclisation of a corresponding 4-chlorosulphonyl-acetidin-2-one
Inventor: COPP JAMES DENSMORE
IPC: C07C/
Filed: 1990-05-11
Abstract: 3-Exomethylenecepham sulfoxide esters are obtained in improved yields via cyclization of 3-methyl-2-(4-chlorosulfinyl-2-oxo-3-acylamino-1-azetidinyl)-3-butenoic acid esters under anhydrous conditions with stannic chloride in the presence of both an oxo compound, e.g., an ether such as diethyl ether, a ketone such as acetone or methylethyl ketone, and an unsaturated compound, e.g., an alkene such as 1- or 2-hexene, a non-conjugated alkadiene such as 1,4-hexadiene, a cycloalkene such as cyclohexene, an allene, or a non-conjugated cycloalkadiene such as 1,4-cyclohexadiene.
Patent NZ-234492-A (NZ)
Title: Annexines (ca 2+ dependent phospholipid binding proteins) and their production by purification
Inventor: REUTELINGSPERGER CHRISTIAAN
IPC: C07K14/195
Filed: 1990-07-13
Abstract: The present invention relates to processes for purifying annexines. The overall process includes the steps of preparing a homogenized cell preparation and adjusting the pH to about 8.0 to 10.0, adding at least one bivalent cation, adding a phospholipid, washing the insoluble cell residue to remove the soluble constituents, and extracting the annexines from the cell residue with a chelating agent. This process initially promotes the adsorption of the annexines onto the insoluble cell residue or membrane of the host organism. The adsorption step makes it possible to eliminate unwanted soluble matter from the homogenized material by simple washing. Desorption is accomplished by using a chelating agent.
Patent NZ-236487-A (NZ)
Title: Laminate suitable for forming a nicotine-containment pouch, comprising an acrylonitrile/methyl acrylate grafted nitrile rubber layer and a barrier layer for preventing nicotine degradation
Inventor: HUNT JAMES A
IPC: B65D85/84
Filed: 1990-12-17
Abstract: The invention herein pertains to methods and materials for producing a nicotine maintenance pouch. Laminates comprising a nicotine barrier layer and a nicotine degradation agent barrier layer are disclosed. In a preferred embodiment, the nicotine barrier layer comprises a nitrile rubber modified acrylonitrilemethyl acrylate copolymer. An especially preferred nicotine barrier material comprises, by weight percent, 75% acrylonitrile, and 25% methyl acrylate with 10% butadiene (AN-MA/B). The nicotine degradation agent barrier layer is preferably aluminum foil. In an especially preferred embodiment, the laminate comprises a layer of AN-MA/B adhered to a layer of aluminum foil, which in turn is adhered to a layer of paper stock. Pouches comprising a self-sealed nicotine barrier layer and a nicotine degradation agent barrier layer are disclosed. These pouches are preferably formed from the laminates above. A method for production of pouches comprises: (a) providing a laminate including a self-sealable nicotine barrier layer and a nicotine degradation agent barrier layer; and (b) sealing the self-sealable nicotine barrier layer to enclose a nicotine device.
Patent NZ-236618-A (NZ)
Title: Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
Inventor: BURK ROBERT ROLAND
IPC: A61K38/00
Filed: 1990-12-21
Abstract: A composition for the treatment of osteoporosis in mammals comprising Insulin-like Growth Factor I (IGF-I) and method of treating osteoporosis therewith is disclosed.
Patent NZ-283022-A (NZ)
Title: Use of antagonists of the vitronectin receptor alpha v beta 3 (integrin receptor) in the manufacture of a medicament for treating angiogenesis
Inventor: BROOKS PETER
IPC: A61K39/00
Filed: 1995-03-09
Abstract: Use of an anti-av-b3 antibody in the manufacture of a medicament for inhibiting angiogenesis in a solid tumour, inducing solid tumor tissue regression, inhibiting solid tumor tissue growth undergoing neovascularization, treating inflamed tissue in which neovascularization is occurring, treating restenosis in a tissue wherein smooth muscle cell migration occurs following angioplasty and reducing blood supply to a tissue required to support new growth of said tissue in a patient.
Patent NZ-288872-A (NZ)
Title: Closure having a compartment with a door which can be opened when the compartment is compressed
Inventor: PLESTER GEORGE
IPC: B65D51/28
Filed: 1995-06-09
Abstract: A closure for a beverage bottle includes a recessed compartment for accommodating a hidden prize or gift therein for promotional purposes. The compartment has an access opening with a snap-fit door therein. When the closure is on the beverage bottle the door can not be opened. However, when the closure is removed from the bottle it may be squeezed to snap open the door and provide access to the compartment to expose the prize or gift.
Patent NZ-296010-A (NZ)
Title: Medicament carrier with at least one carrier screen portion for a dry powder inhalator
Inventor: VAN OORT MICHIEL M
IPC: A61M15/00
Filed: 1995-10-19
Abstract: A medicament carrier for use in a dry powder inhalator device and a process for forming the same wherein the medicament carrier has at least one carrier screen portion. The carrier screen portion defines a plurality of interstices therein and carries a powdered medicament which may be applied in a suspension and the suspending agent then evaporated off and which is loaded onto the carrier screen portion surface such that the interstices of the carrier screen portion are at least partially open and free of the dry powdered medicament. <IMAGE>
Patent NZ-297049-A (NZ)
Title: Aircraft seat, converts to bed, seating portion moves on trolley
Inventor: DRYBURGH IAN
IPC: B60N2/90
Filed: 1995-12-11
Abstract: A seating unit (1) comprises a fixed housing (10) containing a primary seat with a reclinable back arranged to recline in such a manner that it remains within the housing. The seating unit is suitable for a aircraft cabin and may further comprise a leg-rest arranged to cooperate with the seating portion to form part of a substantially flat surface when the back is reclined in a substantially horizontal position. The seating unit may further comprise a secondary seat (3) positioned to face the primary seat, the secondary seat having a seating portion positioned to cooperate with the leg-rest of the primary seat to form a portion of the substantially flat surface when the back of the primary seat is reclined in the substantially horizontal position. Privacy between seats and use of available space within an aircraft cabin may be optimised by arranging at least some of the seats in an echelon.
Patent NZ-316822-A (NZ)
Title: Cyclic peptide analogs of somatostatin
Inventor: COY DAVID H
IPC: C07K/
Filed: 1996-09-04
Abstract: A cyclic peptide analog of somatostatin wherein a disulfide bond links the N-terminus residue and the C-terminus residue.
Patent NZ-331232-A (NZ)
Title: Treating dust mite allergies using peptide formulations
Inventor: CHEN XIAN
IPC: A47C16/02
Filed: 1995-04-12
Abstract: Disclosed are therapeutic compositions and multipeptide formulations of peptides and modified peptides of Group I and Group II Der p and Der f derived protein allergens. Such therapeutic compositions and multipeptide formulations are the result of a preformulation scheme to develop an optimized drug product for therapeutic treatment of humans suffering from allergy to house dust mite allergens. The Der p and Der f peptides and modified peptides in accordance with the invention possess certain unique characteristics which render them particularly suitable for drug product formulation. Therapeutic compositions and multipeptide formulations disclosed have been optimized to accommodate and maintain the unique characteristics of the peptides and modified peptides derived from house dust mite protein allergens and at the same time provide maximum therapeutic effect when used in therapeutic regimens for the treatment of house dust mite allergy in humans. Also disclosed are modified peptides derived from Der p I and Der p II protein allergens.
Patent NZ-334211-A (NZ)
Title: Antibody fragment comprising a linear heavy chain associated with two light chain fragments
Inventor: RINDERKNECHT ERNST H
IPC: C07K16/00
Filed: 1999-02-16
Abstract: A process for purifying an antibody fragment comprising culturing a host cell comprising nucleic acid encoding the heavy chain fragment and a light chain fragment so that the nucleic acid is expressed and recovering the antibody fragment from the host cell culture. An antibody fragment which comprises a linear VH-CH1-VH-CH1 Heavy chain fragment associated with two light chain fragments, wherein the C-terminus of CH1 is joined directly to the N-terminus of VH at the Fd-Fd junction of the heavy chain fragment is also provided.
Patent NZ-335159-A (NZ)
Title: Benzimidazole-2-carbamates for the treatment of HIV, viral infections and inhibits the growth of cancers and tumours
Inventor: CAMDEN JAMES BERGER
IPC: A61K31/4184
Filed: 1997-11-26
Abstract: A pharmaceutical composition that inhibits the growth of tumours and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative having formula (I). Wherein; R is selected from the group consisting of hydroxyl, amino and -CO2R' where R' is selected from the group consisting of C1-8alkoxy, C1-8haloalkyl, C1-8alkenyl, C1-8cycloalkyl, C1-8alkyl, CH3CH2(OCH2CH2)n, CH3CH2CH2(OCH2CH2CH2)n and (CH3)2CH-(OCH(CH3)CH2)n where n is 1-3.
Patent NZ-501141-A (NZ)
Title: Bed support comprising pockets for transverse slats, and a button on a slat for a fastening strip attached to each longitudinal rail
Inventor: PFISTER ADOLF
IPC: A47C23/06
Filed: 1998-04-28
Abstract: A bed support having two resilient longitudinal rails (1) arranged spaced apart and parallel with respect to each other, and a plurality of transverse slats (2) arranged in a grate-like manner is described.  The support has a plurality of pockets (3) oriented transversely with respect to a longitudinal direction and into which are positioned ends of the transverse slats (2) are arranged on the longitudinal rails (1), and wherein at least one fastening means (5) for fixing the transverse slats (2) and the longitudinal rails (1) in place in relation to each other is connected with each of the longitudinal rails (1).  The support has at least one fastening strip (52) attached on each of the longitudinal rails (1) transversely with respect to the longitudinal direction and oriented toward the other one of the longitudinal rails (1), and a fastening button (20) on a nearest of the transverse slats (2) fastening the fastening strip (52) on the transverse slat (2).
Patent NZ-507845-A (NZ)
Title: Liquid solutions and powders containing nicotine as smoking cessation aids
Inventor: WESTMAN ERIC C
IPC: A61P25/28
Filed: 1999-04-21
Abstract: A palatably acceptable solution for providing nicotine to  humans,  said  solution comprising  an  acidic  solution containing nicotine so as to achieve a selected blood  level of  nicotine.   Such  solutions  can  be  used  as  smoking- cessation aids .
Patent NZ-508130-A (NZ)
Title: Compositions in the manufacture of a medicament for treatment of dysmenorrhea
Inventor: HARRISON DONALD C
IPC: A61K9/20
Filed: 2000-11-13
Abstract: Use of compositions in the manufacture of a medicament for the treatment of dysmenorrhea.  Medicaments include pharmaceutical agents selected from the group consisting of nonsteroidal anti-inflammatory drugs, anti-prostaglandins, prostaglandin inhibitors, local anaesthetics, calcium channel blockers, potassium channel blockers, beta-adrenergic agonists, leukotriene blocking agents, smooth muscle inhibitors, vasodilators, and drugs capable of inhibiting dyskinetic muscle contraction. The nonsteroidal anti-inflammatory drugs are selected from the group consisting of Aspirin, Ibuprofen, Indomethacin, Phenylbutazone, Bromfenac, Fenamate, Sulindac, Nabumetone, Ketorolac, and Naproxen; wherein said local anaesthetics are selected from the group consisting of Lidocaine, Mepivacaine, Etidocaine, Bupivacaine, 2-Chloroprocaine hydrochloride, Procaine, and Tetracaine hydrochloride; wherein said calcium channel antagonists are selected from the group consisting of Diltaizem, Israpidine, Nimodipine, Felodipine, Verapamil, Nifedipine, Nicardipine, and Bepridil; wherein said potassium channel blockers are selected from the group consisting of Dofetilide, E-4031, Almokalant, Sematilide, Ambasilide, Azimilide, Tedisamil, RP58866, Sotalol, Piroxicam, and Ibutilide; herein said beta-adrenergic agonists are selected from the group consisting of Terbutaline, Salbutamol, Metaproterenol, and Ritodrine; and wherein said vasodilators are selected from the group consisting of nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate.
Patent NZ-510671-A (NZ)
Title: Equine multi-purpose protector boot with rim extending around the sole , at least one side flap on each side of the sole , compressible cover for the flaps and a heel with fastening straps
Inventor: MACDONALD DAVID DUNCAN
IPC: A01K13/00
Filed: 1999-09-23
Abstract: An equine multi-purpose protector boot comprising: (a) a sole member (1) rigid enough to resist lateral movement of the hoof with an upwardly depending rim extending around its periphery at least at the toe and at each side, the inner surface of said rim being substantially vertical at least in the region of the sides; (b) at least one flexible side flap (17) located at each side of the hoof, attached to or integral with the sole member; (c) an outer compressive cover (19) provided with means to force the side flap (17) into conformation with the shape of the hoof; (d) a flexible heel member attached to the rear of the sole member and including at least one fastening strap (16) adapted to pass around the pastern bone within the range of 2 to 3.5 cm above the coronary band.
Patent NZ-518833-A (NZ)
Title: A water craft inflatable fender system
Inventor: SCHMIDT STEVE
IPC: B63B59/02
Filed: 2000-10-11
Abstract: A water craft fender system which utilises an inflatable bladder (1) having an outer cover (10) which has edges shaped (11) to enclose a bolt rope (12). The edges (11) with the bolt rope are inserted into grooves (8) of bolt rope holders (6, 7) which extend around the hull of the water craft. The ends of the bolt rope are secured to a bolt rope locking device which is formed of two parts (15, 16), one of which is adapted to be attached to the hull of the water craft and the second part engages with the first part to grip the ends of the bolt rope.
Patent NZ-519815-A (NZ)
Title: Device for moving a medical apparatus in a controlled manner
Inventor: SUHM NORBERT
IPC: A61B6/00
Filed: 2000-01-14
Abstract: The apparatus relates to the moving of an X-ray apparatus in a controlled manner. The apparatus is embodied as a C-bow (9) that can be displaced in parallel in relation to at least two axes (18; 19) and is mounted on a pedestal (31) in a rotatable manner in relation to three axes (18; 19; 21). Said pedestal comprises rollers (3) which can be driven by a motor. The direction of said rollers can be controlled. Each movement of the C-bow (9) is carried out in relation to a system of co-ordinates (29) and by means of controllable drive devices (6; 7; 37; 38). Said system is stationary in relation to the room. The drive devices (6; 7; 37; 38) are controlled by means of a computer (23) or a control device (39; 48) which can be controlled by means of a sterile control console or is voice-controlled. Adjusted positions or projections of the C-bow (9) can be stored in the computer (23) in such a way that a desired position or projection can be reproduced. The C-bow (9) can be combined with a surgical navigation system which comprises a position detection device (27). By measuring a reference base (51) that is provided with optical markers (28) and is applied to a patient (12) changes in the position of the patient (12) can thus be considered in such a way that an adjusted position and projection of the C-bow (9) can be reproduced after the patient (12) has changed position.
Patent NZ-531355-A (NZ)
Title: Distributed transmission of traffic flows in communication networks
Inventor: SCHRODI KARL
IPC: H04L12/54
Filed: 2002-10-04
Abstract: Network nodes (1-15) of a packet-orientated communication network (100), the nodes of which are interconnected according to the topology of the network in such a way that a plurality of paths exists between the network nodes, that comprises the following: (a) The network node is contained in at least one distribution fan (VF) that is derived from the network topology for a specific communication relation between a network node configured as a transmitting node (A, C) and a network node configured as a receiving node (B, D) and comprises all the network nodes and routes that can expediently be used for distributed transmission of traffic streams (VS) assigned to communication relation in the communication network; (b) A branch pattern (I, t, d) is defined for the network node, onto which the distribution fan is mapped and by means of which a group (B) of outgoing ports (P) of the network node is determined, to which the traffic streams assigned to the distribution fan are to be distributed, whereby the routes assigned to the ports lead to at least two different adjacent network nodes; and (c) At least when at least one traffic stream is currently transmitted in a distributed manner by the network node according to the branch pattern, the network node comprises at least one queuing system for the branch pattern that comprises at least one queue.
Patent NZ-531673-A (NZ)
Title: Novel 1,2,4-triazole compounds
Inventor: NAKAMURA HIROSHI
IPC: C07D311/16
Filed: 2002-12-03
Abstract: Disclosed are 1,2,4-triazole compounds of formula (1), wherein; R2 is an optionally substituted pyridyl, R1 is an optionally substituted pyridyl, pyridine-N-oxide, or phenyl, and R3 is H or substituted alkyl. The compounds are used for the manufacture for medicaments for inhibiting xanthine oxidase, or as an anti-gout or anti-hyperuricemic agent.
Patent NZ-532926-A (NZ)
Title: Urea substituted imidazopyridines and pharmaceutical compositions for inducing cytokine biosynthesis and treating viral and neoplastic diseases
Inventor: DELLARIA JOSEPH FRED
IPC: A61P17/00
Filed: 2002-06-07
Abstract: A compound of formula (I) is described wherein: X is alkylene or alkenylene; Y is -CO- or -CS-; Z is -NR6-, -NR6-CO-, -NR6-SO2- or -NR7-; R1 is aryl, heteroaryl, heterocyclyl, alkyl or alkenyl each which may be unsubstituted or substituted; R2 is selected from H, alkyl, alkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkyl-O-alkyl, alkyl-S-alkyl, alkyl-O-aryl, alkyl-S-aryl, alkyl-O-alkenyl, alkyl-S-alkenyl and alkyl or alkenyl substituted; R3 and R4 are selected from hydrogen, alkyl, alkenyl, halogen, alkoxy, amino, alkylamino, dialkylamino and alkylthio; R5 is H or C1-10 alkyl, or R5 can join with X to form a ring that contains one or two hetero atoms; R6 is H or C1-10alkyl; R7 is H or C1-10alkyl which may be interrupted by a heteroatom or when R1 is alkyl, R7 and R1 can join to form a ring. A pharmaceutical composition comprising the compound is useful for inducing cytokine biosynthesis, in treating viral disease and for treating a neoplastic disease.
Patent NZ-534746-A (NZ)
Title: Palatable oral suspension and method
Inventor: ULLAH ISMAT
IPC: A61K47/18
Filed: 2003-03-06
Abstract: A pharmaceutical composition in the form of a dry powder comprising particles of a readily water soluble drug, in particular des-quinolone, which when solubilised has a bitter taste and which particles are mixed with one or more alkaline pH modifying agents that generate a pH environment in water to effect reduction in solubility of drug or precipitation of drug so that upon addition of water thereto, the particles are rendered substantially insoluble or form an in-situ precipitate suspended in the water and the resulting suspension is essentially free of bitter taste, wherein the drug is rendered free of bitter taste without use or need for polymer or wax coating or microencapsulation.
Patent NZ-539336-A (NZ)
Title: System and method for creating a display card
Inventor: OLENICK MICHAEL
IPC: G06K19/04
Filed: 2003-09-15
Abstract: A system and method that enable a user such as a visitor to a facility to create a photographic identification card for themselves are disclosed. The user terminal 14 prompts a user to enter identifying information including their name, and takes their photograph. An identification badge that may include a barcode and unique identification number is produced for the user. The user may be presented with a preview of the identification as the identification card is to be printed. Upon exiting the location, the user may scan the barcode or enter the unique identification number to sign out of the system and exit the location. A user activity log may be maintained at a server such that each time an identification card is created, printed or signed out, the log is updated with information regarding the user information, date, time, location or other information.
Patent NZ-539823-A (NZ)
Title: Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
Inventor: BRYANT JUDI
IPC: C07D239/46
Filed: 2003-11-28
Abstract: This disclosure relates to pyrimidine derivatives of general formula (I) as inhibitors of kinases, their production as well as their use as medications for treating various diseases, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-541699-A (NZ)
Title: Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
Inventor: BERNOTAS RONALD CHARLES
IPC: C07D409/12
Filed: 2004-02-10
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are useful in the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor, such as motor disorders, anxiety disorders, cognitive disorders, neurodegenerative disorders including attention deficit disorder; obsessive compulsive disorder; withdrawal from drug, alcohol or nicotine addiction; schizophrenia; depression; and Alzheimer's disease; stroke; head trauma; and neuropathic pain.